News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Hears Patient Testimony on Roche Holding AG (RHHBF.PK)'s Avastin for Breast Cancer in Rare Two-Day Hearing


6/29/2011 8:26:08 AM

Breast cancer patients testified that Roche Holding AG's (ROG.VX) Avastin saved their lives as U.S. health officials weighed whether the world's best-selling cancer drug should remain approved for that condition. At stake in the hearing that began Tuesday is nearly $1 billion in annual Avastin revenues, the hopes of cancer patients and the resolve of the Food and Drug Administration to stick to data-based decisions. "I am alive due to Avastin," said 66-year-old Patricia Howard. "I'm a wife, mother, sister, aunt and granny. I'm not just a statistic. It's in your hands to make sure I don't become one."

Read at Reuters
Read at WebMD
Read at Time
Read at Boston Globe


comments powered by Disqus
Reuters
WebMD
Time
Boston Globe
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES